Impacts of the COVID-19 pandemic on healthcare access among patients receiving medication for opioid use disorder.  Jacka BP, Janssen T, Garner BR, Yermash J, Yap KR, Ball EL, Hartzler B, Becker SJ.  Drug Alcohol Depend. 2021 Feb 15;221…

Sharp decline in hospital and emergency department initiated buprenorphine for opioid use disorder during COVID-19 state of emergency in California.  Herring AA, Kalmin M, Speener M, Goodman-Meza D, Snyder H, Campbell A, Moulin A, Shoptaw S.&n…

A chance to do it better: Methadone maintenance treatment in the age of Covid-19.  Frank D.  J Subst Abuse Treat. 2021 Apr;123:108246. doi: 10.1016/j.jsat.2020.108246. Epub 2020 Dec 13. PMID: 33612189; PMCID: PMC7834469. https://www.ncb…

Webinar. Opioidabhängigkeit aktuell vor dem Hintergrund der COVID19 Pandemie (Aufzeichnung, Video, 60:00) Referenten: Prof. Jens Reimer, Dr. Thomas Poehlke Die Veranstaltung ist von der BLÄK mit 1 CME-Punkt anerkannt https://step-initiative.de/de…

TAKE HOME OPIATE SUBSTITUTE THERAPIES (OST) ADVOCACY BRIEF EuroNPUD – European Network of People who use Drugs, 2020 http://www.civilsocietyforumondrugs.eu/wp-content/uploads/2021/02/Advocacy-Brief-F4.pdf

The health and social consequences during the initial period of the COVID-19 pandemic among current and former people who inject drugs: A rapid phone survey in Baltimore, Maryland.  Genberg BL, Astemborski J, Piggott DA, Woodson-Adu T, Kirk GD…